End of induction minimal residual disease alone is not a useful determinant for risk stratified therapy in pediatric T‐cell acute lymphoblastic leukemia

Publisher: John Wiley & Sons Inc

E-ISSN: 1545-5017|1545-5009|11|2040-2043

ISSN: 1545-5009

Source: PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol.1545-5009, Iss.11, 2015-11, pp. : 2040-2043

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract